Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 14pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US6153440: Simultaneous measurement of free triiodothyronine and free thyroxine by equilibrium dialysis and immunoassay
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
14 pages

 
Inventor: Chopra, Inder J.; Calabasas, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 2000-11-28 / 1998-09-23

Application Number: US1998000158872

IPC Code: Advanced: G01N 33/78;
Core: G01N 33/74;
IPC-7: G01N 33/53;
G01N 33/552;
G01N 33/553;
G01N 33/554;
G01N 33/567;

ECLA Code: G01N33/78;

U.S. Class: Current: 436/500; 424/001.49; 435/005; 435/007.1; 435/007.22; 435/007.23; 435/007.32; 435/007.5; 436/504; 436/518; 436/526; 436/527; 436/538; 436/542;
Original: 436/500; 436/504; 436/526; 436/527; 436/518; 436/538; 436/542; 424/001; 424/111; 435/005; 435/007.1; 435/007.22; 435/007.32; 435/007.5; 435/007.23;

Field of Search: 436/527,500,504,538,542,526,518 424/001,111 435/005,7.1,7.22,7.32,7.5,7.23

Priority Number:
1998-09-23  US1998000158872

Abstract: The present invention provides methods for the simultaneous measurement of triiodothyronine (T3) and thyroxine (T4) in biological fluids such as serum by direct equilibrium dialysis and immunoassay. Specifically, the method comprises dialyzing the serum sample to equilibrium in a physiological buffer system so that the free T3 and the free T4 are separated from T3 and T4 bound to serum proteins. The method further comprises combining a measured quantity of the dialyzed serum sample having free T3 and free T4 with reagents comprising a measured quantity of T3 labelled with a detectable marker and a measured quantity of T4 labelled with a detectable marker; an anti-T3 antibody of sufficient specificity and in sufficient quantity to bind a measurable quantity of the free T3, and an anti-T4 antibody of sufficient specificity and in sufficient quantity to bind a measurable quantity of the free T4. The method then comprises allowing reaction of the free T3 and the free T4 and the labelled T3 and the labelled T4, with the anti-T3 antibody and the anti-T4 antibody to proceed substantially to equilibrium to thereby produce antibody bound labelled T3 and antibody bound labelled T4. Finally, the method comprises separating the unbound labelled T3 from the antibody bound labelled T3 and the unbound labelled T4 from the antibody bound labelled T4 ; and determining the levels of T3 and T4 in the sample by comparing relative amounts of antibody bound labelled T3 and T4 and unbound labelled T3 and T4. In one embodiment of this method, the assay is a radioimmunoassay.

Attorney, Agent or Firm: Gates & Cooper ;

Primary / Asst. Examiners: Minnifield, Nita; Baskar, Padma

INPADOC Legal Status: Show legal status actions

Family: None

First Claim:
Show all 18 claims
What is claimed is:     1. An immunoassay method for the simultaneous measurement of free thyroxine (T4) and free triiodo-L-thyronine (T3) thyroid hormone concentrations in a serum sample comprising the steps of:
  • (a) dialyzing the serum sample to equilibrium in a physiological buffer system so that the free T3 and the free T4 are separated from T3 and T4 bound to serum proteins;
  • (b) combining a measured quantity of the dialyzed serum sample having free T3 and free T4 with reagents comprising:
    • (i) a measured quantity of T3 labelled with a detectable marker and a measured quantity of T4 labelled with a detectable marker;
    • (ii) an anti-T3 antibody of sufficient specificity and in sufficient quantity to bind a measurable quantity of the free T3, and an anti-T4 antibody of sufficient specificity and in sufficient quantity to bind a measurable quantity of the free T4 ;
  • (c) allowing reaction of the free T3 and the free T4 and the labelled T3 and the labelled T4, with the anti-T3 antibody and the anti-T4 antibody to proceed substantially to equilibrium to thereby produce antibody bound labelled T3 and antibody bound labelled T4 ;
  • (d) separating the unbound labelled T3 from the antibody bound labelled T3 and the unbound labelled T4 from the antibody bound labelled T4 ; and
  • (e) determining the concentrations of T3 and T4 in the sample by comparing relative amounts of antibody bound labelled T3 and T4 and unbound labelled T3 and T4.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

       
U.S. References: Go to Result Set: All U.S. references   |  No patents reference this one   |   Backward references (12)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 9pp US3911096  1975-10 Chopra  Professional Staff Association of the Los Angeles County Harbor General Hospital Radioimmunoassay for measurement of thyroxine (T4) and triiodothyonine (T3) in blood serum
Buy PDF- 7pp US3928553  1975-12 Hollander  New York University Radioimmunoassay method for triiodothyronine and thyroxine
Buy PDF- 4pp US3981981  1976-09 Reunanen   Method of radioimmunoassay employing diffusion
Buy PDF- 6pp US4034073  1977-07 Weetall  Corning Glass Works Composite for biased solid phase radioimmunoassay of triiodothyronine and thyroxine
Buy PDF- 6pp US4108974  1978-08 Wegfarht et al.  Bio-Rad Laboratories, Inc. Radioimmunoassay for thyroid hormone
Buy PDF- 10pp US4225576  1980-09 Denning et al.  Miles Laboratories, Inc. Combined radioimmunoassay for triiodothyronine and thyroxine
Buy PDF- 5pp US4229812  1980-10 Holloway  The United States of America as represented by the Secretary of the Navy Apparatus for securing a ferroelectric stack to a weighted projection surface
Buy PDF- 8pp US4292296  1981-09 Parsons, Jr.  Baxter Travenol Laboratories, Inc. Diagnostic method
Buy PDF- 10pp US4963256  1990-10 Nelson  Nichols Institute Diagnostics Dialysis cell
Buy PDF- 14pp US4966838  1990-10 Ferrua et al.  Compagnie Oris Industrie S.A. Process for the immunological quantitative determination of T3 and/or T4 thyroid hormones, using thyroglobulin
Buy PDF- 17pp US5366859  1994-11 Miyoshi et al.  Mitsubishi Petrochemical Co., Ltd. Radioimmunoassay method
Buy PDF- 9pp US5639670  1997-06 Bergmann et al.  B.R.A.H.M.S. Diagnostica GmbH Determination of free thyroid hormones by competitive immunoassay
       
Foreign References: None

Other References:
  • T. Yamamoto et al. (1975) Folia Endocrinology 20;51(2):76-84.
  • J.G. Lundgren et al. (1976) Acta Endocrinol. Mar;81(3):487-94.
  • P. Liu et al. (1978) Sci. Sin (B) Feb;30(2):169-75.
  • M.L. Brown et al. (1977) J. Nucl. Med. Mar; 18(3):300-4. (5 pages) Cited by 2 patents
  • Y.S. Wang (1985) Clin. Chem. Apr;31(4):517-22. (6 pages) Cited by 2 patents
  • C. Blake et al. (1982) Clin. Chem. Jul;28(7):1469-73. (5 pages) Cited by 5 patents
  • S.P. Haynes et al. (1977) Ann. Clin. Biochem. Jan;14(1)12-5. (4 pages)
  • T. Mitsuma et al. (1972) Mar 24, 46(6):2107-13. Cited by 3 patents
  • P. Carayon et al. (1974) Ann Endocrinol May-Jun;35(3)275-6. (2 pages)
  • J.T. Nicoloffet al. (1972) J. Clin. Invest. Mar;51(3):473-83.
  • J.C. Nelson et al. (1979) J. Clin. Lab. Invest. 39:53-59.
  • R. Kannan et al. (1984) Endocrinology 115:1710-1716. (7 pages)
  • S. Melmed et al. (1981) J. Clin. Enocrinol. Metab. 53:997-1001. (5 pages)
  • J.C. Jaune et al. (1996) Thyroid 6:76-83.
  • M.I. Surks et al. (1988) J. Clin. Endocrinol Metab. 67:1031-9. (9 pages)
  • J. Faber et al. (1997) J. Clin. endocrinol. Metabl, 65:316-320.
  • I.J. Chopra et al. (1979) Ann Intern Med. 90:905-12. (8 pages)
  • F. Bermudez et al. (1995) J. Clin. Endocrinol Metab. 41:27-40.
  • J.R. Stockigt et al. (1913) 29:1408-10.
  • R. Ekins et al. (1985) Lancet 1:782. (1 pages)
  • M.N. Alexander (1986) Clin. Chem. 32:417. (1 pages) Cited by 2 patents
  • I.J. Chopra et al. (1980) J. Clin. Endocrinol Metab. 51:135-143. (9 pages)
  • T. Olsen (1979) Scand. J. Clin. Lab. Invest 39:53-59. (7 pages)
  • S.W. Spaulding et al. (1972) J. Clin. Endocrinol Metab. 34:974-82.
  • C.H.G. Irving (1974) J. Clin. Endocrinol Metab. 38:655-62.
  • I.J. Chopra (1974) J. Cl in. Invest. 54:583-592. (10 pages)
  • I.J. Chopra (1996) Thyroid 6(4):255-259. (5 pages) [ISI abstract]
  • J.C. Nelson et al. (1988) Clin Chem 34(9):1737-1744. (8 pages)
  • IT Chopra (1997) Journal of Clinical Endocrinology and Metabolism 82(2):329-334. (6 pages) [ISI abstract]
  • Docter. R, et al, Free thyroxine assessed with three assays in sera of patient with nonthyrodial illness and subjects with abnormal concentrations of thryoxine-binding proteins. Clinical chemistry, vol. 39, No.8, pp. 1668-1674, 1993. (7 pages) [ISI abstract]


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help